GLOW is a multi-compound research formulation containing GHK-Cu, TB-500, and BPC-157, selected for laboratory investigation of distinct and potentially interacting cellular signaling pathways.
GHK-Cu is a copper-binding peptide studied in relation to gene expression, fibroblast activity, extracellular matrix regulation, collagen synthesis, oxidative signaling, and angiogenic pathways.
TB-500, a synthetic peptide associated with thymosin beta-4 research, has been investigated for its interactions with actin, cytoskeletal organization, cellular migration, and angiogenic signaling.
BPC-157 is an experimental peptide studied primarily in preclinical models involving cellular migration, nitric oxide signaling, angiogenic pathways, and inflammatory signaling mechanisms.
The combination provides a multi-component research material for investigating cellular signaling, extracellular matrix biology, cytoskeletal activity, angiogenesis, and related biochemical pathways under controlled experimental conditions.
GLOW is supplied exclusively for laboratory research and analytical purposes. Not for human or animal consumption. Not intended for diagnostic, therapeutic, or clinical use.
